BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 3889035)

  • 21. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.
    Sklar CA; Rothenberg S; Blumberg D; Oberfield SE; Levine LS; David R
    J Clin Endocrinol Metab; 1991 Oct; 73(4):734-8. PubMed ID: 1909701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum concentrations of type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate.
    Hertel NT; Stoltenberg M; Juul A; Main KM; Müller J; Nielsen CT; Lorenzen I; Skakkebaek NE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):924-7. PubMed ID: 8473407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin.
    Laue L; Jones J; Barnes KM; Cutler GB
    J Clin Endocrinol Metab; 1993 Jan; 76(1):151-5. PubMed ID: 8421081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of long-acting analog of luteinizing hormone-releasing hormone on growth hormone secretory dynamics in children with precocious puberty.
    DiMartino-Nardi J; Wu R; Fishman K; Saenger P
    J Clin Endocrinol Metab; 1991 Oct; 73(4):902-6. PubMed ID: 1909708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gonadotropin and alpha-subunit secretion during long term pituitary suppression by D-Trp6-luteinizing hormone-releasing hormone microcapsules as treatment of precocious puberty.
    Lahlou N; Roger M; Chaussain JL; Feinstein MC; Sultan C; Toublanc JE; Schally AV; Scholler R
    J Clin Endocrinol Metab; 1987 Nov; 65(5):946-53. PubMed ID: 2959680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult height in precocious puberty after long-term treatment with deslorelin.
    Oerter KE; Manasco P; Barnes KM; Jones J; Hill S; Cutler GB
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1235-40. PubMed ID: 1955504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of growth hormone binding protein in children with normal and precocious puberty: relation to age, gender, body composition and gonadal steroids.
    Juul A; Fisker S; Scheike T; Hertel T; Müller J; Orskov H; Skakkebaek NE
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):165-72. PubMed ID: 10671943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
    Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
    J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome.
    Feuillan PP; Jones J; Cutler GB
    J Clin Endocrinol Metab; 1993 Sep; 77(3):647-51. PubMed ID: 8370686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precocious puberty associated with neurofibromatosis and optic gliomas. Treatment with luteinizing hormone releasing hormone analogue.
    Laue L; Comite F; Hench K; Loriaux DL; Cutler GB; Pescovitz OH
    Am J Dis Child; 1985 Nov; 139(11):1097-100. PubMed ID: 3933329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
    Mansfield MJ; Beardsworth DE; Loughlin JS; Crawford JD; Bode HH; Rivier J; Vale W; Kushner DC; Crigler JF; Crowley WF
    N Engl J Med; 1983 Nov; 309(21):1286-90. PubMed ID: 6415479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of luteinizing hormone-releasing hormone analog for central precocious puberty on growth hormone (GH) and GH-binding protein.
    DiMartino-Nardi J; Wu R; Varner R; Wong WL; Saenger P
    J Clin Endocrinol Metab; 1994 Mar; 78(3):664-8. PubMed ID: 8126139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone loss during gonadotropin-releasing hormone agonist treatment in girls with true precocious puberty is not due to an impairment of calcitonin secretion.
    Saggese G; Bertelloni S; Baroncelli GI; Pardi D; Cinquanta L
    J Endocrinol Invest; 1991 Mar; 14(3):231-6. PubMed ID: 1830057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatomedin-C levels in children and adolescents with gonadal dysgenesis: differences from age-matched normal females and effect of chronic estrogen replacement therapy.
    Cuttler L; Van Vliet G; Conte FA; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1087-92. PubMed ID: 4039732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of changing gonadotropin-releasing hormone pulse frequency on puberty.
    Bridges NA; Hindmarsh PC; Matthews DR; Brook CG
    J Clin Endocrinol Metab; 1994 Sep; 79(3):841-7. PubMed ID: 8077371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Boys with precocious puberty due to hypothalamic hamartoma: reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy.
    Feuillan PP; Jones JV; Barnes KM; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4036-8. PubMed ID: 11095429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases.
    Rosenthal SM; Grumbach MM; Kaplan SL
    J Clin Endocrinol Metab; 1983 Sep; 57(3):571-9. PubMed ID: 6223935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testolactone treatment of precocious puberty in McCune-Albright syndrome.
    Foster CM; Pescovitz OH; Comite F; Feuillan P; Shawker T; Loriaux DL; Cutler GB
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):254-7. PubMed ID: 3925675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of precocious puberty with a long-acting preparation of D-Trp6-LHRH.
    Chaussain JL; Roger M; Couprie C; Lahlou N; Canlorbe P
    Horm Res; 1987; 28(2-4):155-63. PubMed ID: 2969859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.